the aid library

LIST OPTIONS

Filter

3295

National Guidelines for Integrated Diseases Surveillance and Response Uganda

World Health Organization WHO, Regional Office of Africa; Ministry of Health Uganda (2021) C_WHO

3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health Organization (WHO) for member states in African region. The Ministry of Health has been implementing the IDSR strategy since then with success across the country. This strategy prov... more

Download (614)

View PDF (864)

Tanzania Service Provision Assessement Survey (TSPA) 2014-2015 Key Findings

Ministry of Health and Social Welfare, Dar es Salaam, Ministry of Health, Zanzibar, National Bureau of Statistics, Zanzibar, Tanzania, and ICF International (2016) C1

Download (266)

View PDF (581)

The ACT-Accelerator: Two years of impact

World Health Organization WHO (2022) C_WHO

The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.

Download (312)

View PDF (751)

Ökonomische Bewertung in der globalen Gesundheit

Kohler, S.; N.Paul, T. Bärnighausen, P. Geldsetzer (2021) CC

In: Bonk M., Ulrichs T. (eds). Global Health: Das Konzept der Globalen Gesundheit. Berlin: De Gruyter, 2021, pp. 557–580

Download (477)

View PDF (616)

Forschung mit Weitblick - Ein Handbuch für Studierende mit Interesse an Global-Health-Forschung
recommended

Hommes F, Stratil J, Ströbele L, Bruchhausen W Global Health Alliance-Deutschland (GHA-D) (2019) CC

Eine wachsende Anzahl von Studierenden interessiert sich für Global Health. Bisher mangelt es jedoch an ausreichenden Angeboten zur Verwirklichung von studentischen Global-Health-Forschungsprojekten. Um vor diesem Hintergrund interessierte Studierende auf ihrem Weg zum eigenen Global-Health-Forschu... more

Download (305)

View PDF (309)

Morocco: Plan Stratégique national de prévention et de contrôle de la résistance aux antimicrobiens

Royaume du Maroc - Ministère de la Santè (2019) C_WHO

L’antibiorésistance constitue aujourd’hui l’un des grands défis à relever à l’échelle mondiale. Il s’agit d’une menace de santé publique majeure qui impose une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin d... more

Download (260)

View PDF (301)

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended

World Health Organization WHO (2021) C_WHO

23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health... more

Download (222)

View PDF (238)

What are relevant, feasible and effective approaches to promote acceptance, uptake and adherence to physical distancing measures for COVID-19 prevention and control?

Ryan, R.E.; et al. World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Health Evidence Network synthesis report 72

Download (191)

View PDF (284)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (349)

View PDF (354)

Enhancing mental health pre-service training with the mhGAP Intervention Guide: experiences and lessons learned

World Health Organization WHO (2020) C_WHO

This document was designed to inform educators, amongst others, about enhancing the pre-service curriculum with mental health Gap Action Programme Intervention Guide (mhGAP-IG) materials, which can provide future professionals with the theoretical and clinical knowledge they need to provide mental h... more

Download (221)

View PDF (333)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

External Link

Psychological treatments for depression and anxiety disorders in low-and middle-income countries: a meta-analysis

E van‘t Hof, P Cuijpers, W Waheed, DJ Stein (2011) CC

Afr J Psychiatry 2011;14:200-207

Download (226)

View PDF (496)

Ne polluez pas mon avenir ! L'impact environnemental sur la santé infantile

World Health Organisation WHO (2017) C_WHO

En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra... more

Download (271)

View PDF (456)

Report of the 4TH Global Scientific Meeting on Trachoma

World Health Organization WHO (2018) C_WHO

Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and, in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can d... more

External Link

Financing Global Health 2013: Transition in an Age of Austerity

Institute for Health Metrics and Evaluation (2014) CC

Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi... more

Download (159)

View PDF (169)

Invisible numbers; The true extent of noncommunicable diseases and what to do about them 2022

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti... more

Download (385)

View PDF (412)

Findings from othe Global Burden of Disease Study 2017

Institute for Health Metrics and Evaluation (IHME), The Lancet (2019) CC

This booklet provides an overview of all findings from the Global Burden of Disease 2017 study. Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, repli... more

External Link

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries

Torres-Rueda S.; S. Sweeney; F. Bozzani et al. BMJ Global Health (2021) C2

COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di... more

Download (223)

View PDF (403)

Ghana National Community Health Worker Training Manual. Module I: Community Health Basics

Ministry of Health, Ghana; World Vision (2013) CC

Download (220)

View PDF (395)

Point-of-use fortification with micronutrient powders (mnp)improving the nutrition of infants and young children aged 6-23 months (Healthcare Providers)

Ministry of Health, Kenya (2020) C1

The micronutrient powders will be distributed at the health facilities where instructions on use will be provided by Health Care Providers. Community Health Volunteers will educate, counsel, and mobilize caregivers at the community level to visit health facilities for nutrition assessment and provis... more

Forschung mit Weitblick - Ein Handbuch für Studierende mit Interesse an Global-Health-Forschung recommended

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages recommended

Forschung mit Weitblick - Ein Handbuch für Studierende mit Interesse an Global-Health-Forschung
recommended

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages
recommended